论文部分内容阅读
目的探讨男性乳腺癌的诊断、治疗及预后特点。方法回顾分析13例男性乳腺癌的临床资料。结果 13例患者中位年龄63岁。TNM分期:I期2例,Ⅱ期7例,Ⅲ期4例。激素受体阳性者占73.1%。13例患者均为浸润性导管癌。腋窝淋巴结转移6例。1例行乳腺癌根治术,11例行改良根治术,1例行区段切除术。获随访13例,1例死亡。结论男性乳腺癌发病率低、发病年龄高、临床分期晚、早期易转移。外科手术联合放、化疗、内分泌治疗是男性乳腺癌的理想治疗方案。男性乳腺癌的预后与临床分期有一定关系。
Objective To investigate the diagnosis, treatment and prognosis of male breast cancer. Methods Retrospective analysis of 13 cases of male breast cancer clinical data. Results The median age of 13 patients was 63 years. TNM staging: I in 2 cases, Ⅱ in 7 cases, Ⅲ in 4 cases. Hormone receptor positive accounted for 73.1%. All 13 patients were invasive ductal carcinoma. Axillary lymph node metastasis in 6 cases. A routine radical mastectomy, 11 cases of modified radical mastectomy, 1 case of segmentectomy. Followed up in 13 cases, 1 patient died. Conclusions Male breast cancer has low incidence, high age of onset, late clinical stage and early stage metastasis. Surgery combined radiotherapy and chemotherapy, endocrine therapy is the ideal treatment for male breast cancer. The prognosis of male breast cancer and clinical stage have a certain relationship.